Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Increases By 24.4%

BiomX Inc. (NYSEAMERICAN:PHGE) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 31,600 shares, a growth of 24.4% from the February 28th total of 25,400 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily volume of 87,400 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their target price on shares of BiomX from $2.00 to $21.00 and gave the company a “buy” rating in a research note on Tuesday.

BiomX Trading Up 27.6 %

Shares of PHGE stock opened at $0.63 on Thursday. BiomX has a 1-year low of $0.48 and a 1-year high of $4.99. The firm has a market cap of $11.44 million, a P/E ratio of -0.20 and a beta of 1.27.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).